C WorldWide Healthcare Select A1/  LU0090908194  /

Fonds
NAV2024-11-14 Chg.-1.9800 Type of yield Investment Focus Investment company
150.8000EUR -1.30% reinvestment Equity Worldwide C WORLDWIDE FUND M. 

Investment strategy

We aim to achieve a long-term growth of your capital by investing in shares of a limited number of attractive companies operating in the healthcare sector, worldwide. The Sub-Fund focuses on large and medium size companies which account for at least 75% of our investments. Smaller size companies may represent up to 25% of the investments. Our investment decisions are based on a thorough financial analysis of companies operating in the healthcare sector, combined with an evaluation of financial markets in the pharmaceutical, medical technology, biotechnology and medical service sectors. It allows us to build a concentrated portfolio of companies of which we have a detailed knowledge and we intimately know to represent the most promising investment opportunities on the long term.
 

Investment goal

We aim to achieve a long-term growth of your capital by investing in shares of a limited number of attractive companies operating in the healthcare sector, worldwide.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Healthcare Index
Business year start: 01-01
Last Distribution: -
Depository bank: Bank of New York Mellon SA/NV
Fund domicile: Luxembourg
Distribution permission: Germany, Czech Republic
Fund manager: Mikael Svensson, Ulf Arvidsson
Fund volume: -
Launch date: 1998-12-15
Investment focus: -

Conditions

Issue surcharge: 0.00%
Max. Administration Fee: 1.60%
Minimum investment: 1,000.00 EUR
Deposit fees: 0.05%
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: C WORLDWIDE FUND M.
Address: P.O. Box 1141, 1011, Luxembourg
Country: Luxembourg
Internet: www.carnegieam.com
 

Assets

Stocks
 
100.00%

Countries

Global
 
100.00%

Branches

Pharma/Biotechnology
 
30.50%
Healthcare appliances
 
27.40%
Pharma, production
 
22.60%
commercial service
 
19.40%
Others
 
0.10%